← Back to Search

Health Literacy Interventions for Smoking

N/A

Waitlist Available

Led By Lorna H. McNeill, MPH,PHD

Research Sponsored by M.D. Anderson Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current smoker with a history of at least 5 cigarettes/day for the last year

Age 18 to 70 years

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

Study Summary

This trial is examining whether different types of messages emphasizing the health consequences of smoking, written at a 5th to 6th grade reading level, will have different effects on smokers with varying levels of health literacy.

Who is the study for?

This trial is for English-speaking smokers aged 18 to 70 who have smoked at least 5 cigarettes daily over the past year. They must have a home address, phone number, and not be using nicotine replacements or enrolled in cessation programs.Check my eligibility

What is being tested?

The study tests how different types of messages about smoking risks affect smokers' intentions to quit and their attitudes towards smoking. It uses audio scripts with matching text that vary by emotionality (fact-based vs. emotional) and framing (benefits of quitting vs. costs of not quitting).See study design

What are the potential side effects?

Since this trial involves listening to messages and answering questionnaires, there are no direct physical side effects associated with medical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I currently smoke at least 5 cigarettes a day and have been doing so for the last year.

Select...

I am between 18 and 70 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Factors that may influence how smokers understand smoking health risk informational messages.

Trial Design

4Treatment groups

Experimental Treatment

Group I: Factual Loss-FramedExperimental Treatment2 Interventions

Smoking Risk Message - Factual Loss-Framed (FLF)

Group II: Factual Gain-FramedExperimental Treatment2 Interventions

Smoking Risk Message - Factual Gain-Framed (FGF)

Group III: Emotional Loss-FramedExperimental Treatment2 Interventions

Smoking Risk Message - Emotional Loss-Framed (ELF)

Group IV: Emotional Gain-FramedExperimental Treatment2 Interventions

Smoking Risk Message - Emotional Gain-Framed (EGF)

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Focus Group

2017

Completed Phase 1

~4060

Questionnaire

2014

Completed Phase 2

~20090

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,932,659 Total Patients Enrolled

63 Trials studying Smoking

53,609 Patients Enrolled for Smoking

M.D. Anderson Cancer CenterLead Sponsor

2,966 Previous Clinical Trials

1,804,287 Total Patients Enrolled

14 Trials studying Smoking

3,901 Patients Enrolled for Smoking

Lorna H. McNeill, MPH,PHDPrincipal InvestigatorM.D. Anderson Cancer Center

Media Library

Focus Group Clinical Trial Eligibility Overview. Trial Name: NCT00684437 — N/A

Smoking Research Study Groups: Factual Loss-Framed, Emotional Loss-Framed, Emotional Gain-Framed, Factual Gain-Framed

Smoking Clinical Trial 2023: Focus Group Highlights & Side Effects. Trial Name: NCT00684437 — N/A

Focus Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT00684437 — N/A

Smoking Patient Testimony for trial: Trial Name: NCT00684437 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the qualifications to partake in this research trial?

"Participants for this medical study must be smokers and between 18 to 70 years old. The researchers are intending to enroll 495 patients in total."

Answered by AI

Does this trial accommodate participants who are over 18 years old?

"This experimental trial has an age range of 18-70, with the lower limit being the legal age of consent."

Answered by AI

Are any new participants being enrolled at this time in the research project?

"According to clinicaltrials.gov, this medical trial is not presently enrolling patients. Initially posted on May 1st 2008 and most recently updated June 29th 2022, the study has currently ended recruitment but there are 64 other trials in progress that may be suitable for those seeking participation."

Answered by AI

Who else is applying?

What state do they live in?

Texas

How old are they?

18 - 65

What site did they apply to?

University of Texas MD Anderson Cancer Center

What portion of applicants met pre-screening criteria?

Did not meet criteria

Met criteria

How many prior treatments have patients received?

Why did patients apply to this trial?

Are they going to pay me. I have tried to quit on my own with no success. I have tried different ways to quit smoking and so far nothing has worked. I’m hoping this trial can not only reach me about the effect of cigarettes on the body but to help me quit smoking as well.

PatientReceived 1 prior treatment

I'm getting older and I'm getting life insurance.. The price is very high and I'm told that if I I quit for a year the price will drop. I ve been smoking a great hole now and I can feel my breath shortening. I want to quiit and patches, gum and cold turkey didn't work.

PatientReceived 2+ prior treatments

Recent research and studies

clinicaltrials.govStudy

Literacy and Smoking Risk Communications

2008. "Literacy and Smoking Risk Communications". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00684437.

All > Smoking